Helical closes $10M seed to turn bio foundation models into systems

Helical, a London-based pharma AI startup, has raised $10M in a seed round led by redalpine to build the application layer that makes biological foundation models usable in pharmaceutical R&D. The platform includes a Virtual Lab for biologists and a Model Factory for ML engineers, both sharing data and models for reproducible, auditable results. Already in production with multiple top-20 global pharma companies including Pfizer, Helical claims to have compressed drug discovery timelines from years to weeks. Notable angel investors include the CEOs of Cohere and HuggingFace.